The Infection Was Already There: What Historical Hepatitis C Research Tells Us

Hepatitis C did not suddenly appear when screening began. By the time routine screening of donated blood for hepatitis C was introduced in the UK, the virus had already been circulating for years. That matters because many people affected by infected blood were transfused long before hepatitis C had even been identified as a distinct virus. It also matters because medical records from those decades may now be incomplete or destroyed, and the absence of a positive hepatitis C test from the 1970s or 1980s cannot simply be treated as evidence that infection was not present. Historical research helps explain why.

What did researchers find?

A study published in the Journal of Infection in 2002 examined hepatitis C prevalence in England and Wales using stored blood samples from adult patients. Researchers compared samples from 1986, 1991 and 1996. Although the measured prevalence varied between the periods, their statistical analysis did not find a significant overall difference between the three years.

Their conclusion was striking: the majority of hepatitis C infections in England and Wales were probably acquired before 1986.

That does not mean every infection identified later came from blood or blood products, nor does it establish how any particular individual became infected. But it provides important historical context. Hepatitis C was already established within the population well before routine screening of donated blood began.

A virus that did not yet have a name

For much of the period now associated with the infected blood scandal, doctors could not test specifically for hepatitis C. The virus itself was not identified until the late 1980s. Before that, unexplained cases of hepatitis following blood transfusion were often described as non-A, non-B hepatitis.

That creates an obvious problem when families are asked decades later to reconstruct what happened. Someone transfused in the 1970s or early 1980s could not have received a hepatitis C diagnosis at the time because the diagnostic test did not yet exist.

Their records may instead contain references to abnormal liver function, jaundice, hepatitis of uncertain type, non-A non-B hepatitis or later liver disease. None of those findings, by themselves, proves hepatitis C infection, but neither should the absence of the words “hepatitis C” in an early medical record be surprising.

Screening came later

Routine screening of UK blood donations for hepatitis C antibodies began in September 1991. By then, people had been receiving transfusions and blood products for decades.

The historical question is therefore not simply: “Was this person diagnosed with hepatitis C at the time?”

For many patients, that would have been impossible.

A more meaningful question is whether the available medical history, transfusion history, later testing and clinical evidence are consistent with an earlier infection. That distinction becomes particularly important where original hospital records have been lost.

What historical prevalence figures can — and cannot — tell us

Research figures are sometimes quoted as though they provide an individual person's probability of having contracted hepatitis C from a transfusion. That is too simplistic.

Population studies tell us about groups of people. They can demonstrate that infection existed within particular populations and periods, identify patterns and help researchers understand when transmission was occurring. They cannot, on their own, prove that a named individual acquired hepatitis C from a particular unit of blood.

For example, a prevalence rate measured among a group of transfusion recipients does not mean that the same percentage of every unit of blood in circulation was infected. Those are completely different claims.

Getting that distinction right matters because the case for recognising historical infection does not need exaggerated statistics. The historical evidence is already significant enough.

Why older transfusion histories matter

The 2002 research found evidence consistent with substantial hepatitis C transmission having occurred before 1986. That sits within a much broader historical picture in which patients received blood and blood products before effective donor screening for hepatitis C was available.

For families trying to establish what happened to somebody decades later, dates matter. A transfusion in 1975, 1983 or 1988 sits within a very different medical and blood-safety environment from one given today.

That does not mean every historical transfusion caused infection. It does mean that historical exposure cannot fairly be judged using modern assumptions about testing and blood safety.

When the evidence has disappeared

The difficulty becomes even greater when medical records no longer exist.

Some families now face an extraordinary evidential problem: they are trying to establish events that happened forty or fifty years ago using records created at a time when hepatitis C could not yet be specifically identified, and some of those records have subsequently been destroyed.

The scientific evidence cannot reconstruct an individual's missing medical file, but it can provide context. It can show that hepatitis C infection was already present during the relevant period, show why a contemporary hepatitis C diagnosis might be absent, and help explain why later clinical evidence may be important when earlier records are incomplete.

Evidence should be used carefully

There is a temptation in campaigning to reach for the largest percentage or the strongest-sounding statistic. We should resist it.

If evidence is overstated, it becomes easier for the wider argument to be dismissed. The stronger approach is to say precisely what the research shows.

The 2002 study does not prove that most historic transfusions transmitted hepatitis C, and it does not prove the source of infection in any individual claimant.

What it does say is that, based on the researchers' analysis, the majority of hepatitis C infections in England and Wales were probably acquired before 1986. That is an important piece of the historical record.

The past cannot be judged as though today's tests existed

One of the central difficulties surrounding historical infected-blood cases is hindsight. Today we understand hepatitis C, test for it routinely and have highly effective treatment. That was not the reality faced by patients decades ago.

People could be infected before the virus had a name, live with infection for years without knowing, and have records describing liver abnormalities without identifying the underlying virus.

By the time hepatitis C testing became available, the original transfusion records could already have been difficult to trace.

That history deserves to be understood on its own terms.

When the records are incomplete, scientific and historical context does not replace individual evidence, but it may help us understand why that evidence is missing in the first place.